Thomas Woiwode's Net Worth

Thomas Woiwode's net worth is estimated to be at least $23,737,820.33 as of 05/27/2024. CoreStreet's estimation of Thomas Woiwode's net worth is based on their sale of stock and current holding of stock.

Thomas Woiwode is Director at Tempest Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,118,644 units of TPST stock on 04/29/2022. Their biggest sale was on 04/27/2018 when they sold 222,258 units of Crispr Therapeutics AG stock for $11,137,348.38. They typically trade 1 times per year.

Total value of insider buys:
  • $12,499,999.84
Total value of insider sells:
  • $11,237,820.49
Most recent insider trade:
  • April 29, 2022

Thomas Woiwode's Insider Trading History

Tempest Therapeutics IncTitleAmountPriceTypeTotal Value
April 29, 2022
Director2,118,644$2.36Buy$4,999,999.84
Aligos Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 20, 2020
Director200,000$15.00Buy$3,000,000.00
Passage Bio IncTitleAmountPriceTypeTotal Value
March 3, 2020
Director225,000$20.00Buy$4,500,000.00
Crispr Therapeutics AGTitleAmountPriceTypeTotal Value
April 27, 2018
Director222,258$50.11Sell$11,137,348.38
Dec. 22, 2017
Director3,059$20.29Sell$62,067.11
Nov. 27, 2017
Director200$20.24Sell$4,048.00
Nov. 24, 2017
Director1,700$20.21Sell$34,357.00